Jump to main content
Jump to site search

Issue 44, 2019
Previous Article Next Article

Carrier-free self-built aspirin nanorods as anti-aggregation agents towards alpha-crystallin-derived peptide aggregates: potential implications in non-invasive cataract therapy

Author affiliations

Abstract

The aggregation of the α-crystallin protein is the pathological hallmark of cataract. In the current work, peptide fragments derived from native α-crystallin were synthesized and explored as a peptide-based crystallin aggregation model towards cataract. The anti-aggregation potential of aspirin was evaluated towards these peptide-generated aggregates as well as towards the α-crystallin aggregate. The results demonstrated that aspirin had the capacity to inhibit crystallin and crystallin-derived peptide aggregation and could act as a potential therapeutic agent in mitigating cataract. Computational studies were also carried out to study the interaction between the model peptides and aspirin. The results revealed the existence of molecular interactions between the peptides and aspirin, which had a significant impact on the secondary structure of the peptides and potentially modulated their assembly and aggregation behavior. The formation of self-built aspirin nanorods was also explored and their ability to inhibit the aggregation of model cataract peptides and α-crystallin aggregation was validated. These findings open up the possibility of using small molecule-based nanotherapeutics for cataract merely through topical applications, which can be beneficial to cataract patients.

Graphical abstract: Carrier-free self-built aspirin nanorods as anti-aggregation agents towards alpha-crystallin-derived peptide aggregates: potential implications in non-invasive cataract therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Jul 2019, accepted on 30 Sep 2019 and first published on 15 Oct 2019


Article type: Paper
DOI: 10.1039/C9TB01435G
J. Mater. Chem. B, 2019,7, 6945-6954

  •   Request permissions

    Carrier-free self-built aspirin nanorods as anti-aggregation agents towards alpha-crystallin-derived peptide aggregates: potential implications in non-invasive cataract therapy

    A. Bisht, M. Sharma, S. Sharma, Md. E. Ali and J. J. Panda, J. Mater. Chem. B, 2019, 7, 6945
    DOI: 10.1039/C9TB01435G

Search articles by author

Spotlight

Advertisements